Skip to main content
Company

SingleCare CEO Rick Bates explains how COVID-19 affects prescriptions

SingleCare logo
By | Apr. 16, 2020
Rick Bates, SingleCare CEO

Key takeaways

  • The COVID-19 pandemic initially caused fear and led to people stockpiling medications, but eventually led to a stabilization with more people filling 90-day prescriptions, often through telehealth services.

  • SingleCare’s mission focuses on ensuring access to affordable medications, which has become even more critical during the global pandemic.

  • In response to the pandemic, SingleCare has shifted its focus towards delivery services to maintain medication access for people sheltering in place.

  • SingleCare is also looking to partner in future testing and vaccine efforts to further support public health during the COVID-19 crisis.

The spread of the novel coronavirus across the U.S. has had an immediate impact on healthcare and how people get, then fill prescriptions. SingleCare CEO and founder, Rick Bates, spoke with Yahoo Finance’s “The Final Round” about how COVID-19 is impacting American’s ability to get the medications they need.

First, there was a lot of fear and stockpiling. Then, it stabilized to 90-day fills for people with chronic conditions, often through telehealth services. SingleCare’s mission is to help everyone access the drugs they need to feel better—at affordable prices, even in times of a global pandemic.

This is why the company has shifted focus to delivery services to improve access points while people shelter in place, and is looking forward to partnering on testing and vaccine efforts in the future.

Watch the full interview below: